Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

AmerisourceBergen set to pass $100bn sales mark for FY 2014

$1bn... AmerisourceBergen topline sales set to be worth 100 times as much for fiscal year 2014

AmerisourceBergen has reported “outstanding operational and financial performance” for the third quarter 2014, and is set to pass the $100bn revenue mark for the fiscal year. 

Related news

News in brief

Strategic partnerships are “flexible, cost-effective and will become the trend over the next few years,” says CRO DZS, which has signed a multi-year deal with SBI Pharmaceuticals.

Hikma has bought defunct manufacturer Ben Venue and says it could reactivate the site in the long-term, despite the transfer of equipment across its sterile injectables network.

Growth of Pharma strategic partnerships with contract development and manufacturing organisations (CDMOs) is driving consolidation, according to an industry report.

Global Industry News

First come, first served? FDA may allow reservation of drug names from in-PharmaTechnologist.com

The US Food and Drug Administration (FDA) is inviting public comment on plans to allow drug companies to reserve proprietary names for medicines as early as the end of Phase II trials.

UK Gov should seek licenses for off-patent drugs in new indications says MP from in-PharmaTechnologist.com

The UK Government should seek licenses to use off-patent drugs in new indications according to MPs who say there is no incentive for pharma firms to apply for such approvals after a product goes generic.

Busy times: US FDA accepts Sandoz's biosimilar filgrastim filing from BioPharma-Reporter.com

Mailroom and legal staff at Sandoz and Amgen are in for a busy six months after the US FDA agreed to review a biosimilar version of the anti-infective, Neupogen.

Ipca halts API shipments to US following 483 at Indian plant from in-PharmaTechnologist.com

Ipca Laboratories has halted shipments to the US of active pharmaceutical ingredients (APIs) made from a facility in India following a US FDA inspection.

Generics: change in pill shape makes patients 66% more likely to quit from in-PharmaTechnologist.com

Switching patients to generic pills of a different shape and colour increases the chances they will end their course of medicine early, according to research.

Lilly swaps dry powders for insulin at Indiana site in post-patent shake-up from in-PharmaTechnologist.com

Patent expiration and a large molecule pipeline has prompted Eli Lilly to repurpose a solid oral dose plant in Indiana.

Thermo Fisher raises guidance on 'fabulous' biopharma services growth from BioPharma-Reporter.com

The biopharma services market keeps expanding and “growth prospects look fabulous,” says Thermo Fisher, reporting better than expected sales across its Life Sciences business for the second quarter 2014.

Spotlight

Petition calls on FDA to amend informed consent requirements

Petition calls on FDA to amend informed consent requirements

The Center for Responsible Science  has asked the US FDA to adopt informed consent rules which ensure that trial participants...

US FDA to set more specific GMP regulations for outsourcing facilities

US FDA to set more specific GMP regulations for outsourcing facilities

Until final regulations are finished, the US FDA has released draft guidance describing the agency’s expectations for...

Parexel taps Middle East, North Africa with Atlas acquisition

Parexel taps Middle East, North Africa with Atlas acquisition

CRO Parexel has shifted its attention overseas with the acquisition of Atlas Medical Services, a provider of...

Trial documents: only 13% of firms are fully paperless, says Veeva

Trial documents: only 13% of firms are fully paperless, says Veeva

Contract research organisations (CROs) have been slow to adopt next-generation means of recording study documents, with only...

Pfizer offers update on risk-sharing deals with Icon, Parexel
Dispatches from DIA

Pfizer offers update on risk-sharing deals with Icon, Parexel

Three years after Pfizer began strategic partnerships with CROs Icon and Parexel, and the companies are still...

Key Industry Events

 

Access all events listing

Our events, Events from partners...